Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12842000 | 0.90 | ALDH1A1 (0.66) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL4336648 | 0.85 | ALDH1A1 (0.90) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL12841607 | 0.83 | ALDH1A1 (0.71) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL12841719 | 0.82 | ALDH1A1 (0.74) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL4340745 | 0.82 | ALDH1A1 (0.97) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL12432242 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL12658437 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL4347038 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL12658438 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT | |
| SCHEMBL14393763 | 0.78 | ALDH1A1 (0.64) | ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1716117-B1 | IONIC UV-A SUNSCREENS AND COMPOSITIONS CONTAINING THEM | DSM IP ASSETS BV (NL) | 2011-05-04 | — | — | EP | disclosed |
| US-7897779-B2 | Ionic UV-A sunscreens and compositions containing them | DSM IP ASSETS B.V. (NL) | 2011-03-01 | — | — | US | disclosed |
| US-20070275090-A1 | Ionic Uv-A Sunscreens and Compositions Containing Them | DSM IP ASSETS B.V. (NL) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070275090-A1 | Ionic Uv-A Sunscreens and Compositions Containing Them | SUN2, ERCC1, UNG | ALDH1A1 173/4885KDM4E 1776/4885SMN1; SMN2 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.